Abstract
The aim of the present study is to determine the efficiency of third year ophthalmology residents from a tertiary hospital in performing preliminary retinal examination to identify eyes at risk retinopathy of prematurity on the basis of retinal fundus findings up to International Classification of Retinopathy of Prematurity (ICROP) Zone II.
This is a single-center, cross-sectional, prospective comparative research conducted from June to October 2015 at a tertiary training hospital in the Philippines. All infants referred for retinopathy of prematurity screening within the study period where included. The presence of retinal vessel dilatation and tortuosity were identified by third year ophthalmology residents using indirect funduscopy. The residents fundus findings were then compared to that of a retina consultant who is proficient in the diagnosis and management of retinopathy of prematurity (ROP). The Kappa index was used to rate inter-observer agreement. The correlation between ROP risk factors and the presence of abnormal retinal vessels were assessed using odd ratio computations. Fisher s exact test was used to determine the correlation between retinopathy of prematurity and the presence of retinal dilatation and tortuosity. The McNemar s test was also applied to determine significant differences in the retinal findings of the consultant and ophthalmology residents.
A total of 82 eyes of 41 premature infants were evaluated to determine if retinal findings observed by ophthalmology residents were comparable to that of a retina consultant. Odds ratios show that age of gestation, birth weight, and history of blood transfusion are significantly associated with the presence of retinopathy of prematurity. Retinal vessel tortuosity and dilatation are also more common among infants diagnosed with retinopathy of prematurity. There was no significant difference between the retinal vascular findings of the retina consultant and the third year ophthalmology resident in terms of identifying retinal vessel dilatation and tortuosity (
After sufficient and in-depth ophthalmology training, third year ophthalmologists, who will be general ophthalmologists in the future, can reliably identify eyes at risk for severe retinopathy of prematurity on the basis of retinal vascular dilatation and/or tortuosity.
Author Contributions
Copyright© 2018
B. Iguban Eleonore, et al.
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Competing interests The authors have declared that no competing interests exist.
Funding Interests:
Citation:
Introduction
Retinopathy of prematurity (ROP) is a proliferative retinal vascular disorder primarily affecting premature or low birth weight infants. Retinopathy of prematurity, in its advanced stages, equates to a high economic burden for both the community and the individual since it affects normal motor, social, language, and intellectual development of the child. Numerous studies have shown that blindness as a result of neglected retinopathy of prematurity is preventable when treatment is done at the appropriate time. Current practice guidelines for ROP screening released in 2006 by the American Academy of Pediatrics, the American Association for Pediatric Ophthalmology and Strabismus (AAPOS), and the American Academy of Ophthalmology (AAO) recommended that retinal screening examination should be done on all infants with the following: (1) birth weight of less than 1500g; (2) gestational age of 32 weeks or less, and (3) birth weight less than 2000g or a gestational age more than 32 weeks but with an unstable clinical course. Screening for ROP should be done between 4-6 weeks of post-natal age or between 31 and 33 weeks of post-conceptional age. The International classification of ROP (ICROP) of 2005 has served as the basis of numerous multicenter studies on ROP during the last two decades. It has enabled a standardized approach in retinal examination and reporting of findings during ROP screening. The ICROP describes retinal findings with emphasis on the extent of the developing vasculature, the location relative to the optic nerve, which is divided into three zones, and the progressive staging of ROP. The International classification of ROP (ICROP) staging for the severity of ROP has five stages, with stage 1 being the least severe, and stage 5 as the most severe characterized by total retinal detachment. Examination of the peripheral retina during ROP screening might not always be possible in hospitals and maternal delivery centers. This may be due to either the lack of awareness of pediatricians and midwives regarding ROP screening guidelines The gradual and long learning curve associated with mastering the skill of ROP screening coupled with the widespread lack of trained ROP specialists in most health institutions and maternal delivery centers in the Philippine communities have caused neonates to go unexamined. Irreversible and severe blindness has occurred in these babies who were not screened and managed timely due to inadequate ROP screening programs. The frequency of undetected ROP in these areas justifies the need to investigate the feasibility of an alternative method of screening done by general ophthalmologists who are more present in the provinces and smaller communities. These general ophthalmologists should be able to identify neonates with risk factors for ROP development, recognize ophthalmological signs of possible ROP such as poorly dilating pupils and hazy ocular media, and detect retinal vascular abnormalities warranting immediate referral to a Retina-ROP subspecialist. The results of this research would pave the way for the inclusion of ROP screening techniques in the Philippine Ophthalmology residency training program. This would ensure that all ophthalmology residency graduates would be able to adequately do preliminary ROP screening and recognize cases that would warrant urgent referral to an Retina-ROP subspecialist for timely management. This, in turn, would lessen, if not eliminate, the occurrence of at-risk babies developing severe visual impairment due to lack of access to an ROP examination in the provinces and local communities. The aim of the present study is to determine the efficacy of third year ophthalmology residents from a tertiary hospital in performing preliminary retinal examination to identify eyes at risk retinopathy of prematurity on the basis of retinal fundus findings up to International Classification of Retinopathy of Prematurity (ICROP) Zone II.
Results
A total of eight (8) third year ophthalmology residents from the PGH- Department of Ophthalmology and Visual Sciences underwent both the pretest and posttest evaluation for the determination of inter-observer agreement. Calculations using Kappa analysis were based on the residents’ assessment of retinal vessel dilatation and tortuosity in a set of pre-determined set of retinal pictures. The study examining group of ophthalmology residents were able to evaluate eighty-two (82) eyes of forty-one (41) premature babies for retinopathy of prematurity screening within the study period. The baseline characteristics of these neonates are tabulated below. The study patients were equally represented in terms of gender, wherein 46% were males and 54% were females. The mean maternal age was 27, and ranges from 16-42 years. Most of the referred babies were born at 30 weeks age of gestation, with birthweights ranging from 890-2200 grams. Mean post-conceptional age upon referral for ROP screening was 36 weeks, and four (4) out of the 82 eyes that were examined had rubeosis on presentation. The correlation between risk factors and the presence of abnormal retinal vessels as diagnosed by the study’s retina consultant were assessed using odd ratio computations with confidence intervals calculated at 95%. The summary of these computations is shown in Computations of odds ratio revealed that there is an increase risk in developing retinal vessel dilatation and/or tortuosity in the presence of the following risk factors, namely: (1) exposure to any method of oxygenation, (2) maternal infection, (3) pre eclampsia/eclampsia, (4) preterm premature rupture of membranes, (5) history of perinatal blood transfusion, (6) neonatal jaundice, (7) lower birth weight, and (8) earlier age of gestation. Most of the risk factors, however, did not show a statistically significant association for the development of abnormal retinal vessels, except for exposure to mechanical ventilation, birth weight and age of gestation. Fisher’s exact test was computed to determine the correlation between retinopathy of prematurity and the presence of retinal dilatation and tortuosity. A significant association was seen between retinal vessel dilatation and tortuosity with the presence of retinopathy of prematurity (see Diagnosis is based on consultant’s assessment. The condition was present on both left and right eye Fisher’s exact test The comparison between the retinal vascular findings of the consultants versus the study examining group are summarized in Note: Note:
Image
No. of residents
Tortuosity
Dilatation
Pre-test
Post-test
Pre-test
Post-test
1
8
8
8
8
8
2
8
0
0
8
0
3
8
8
8
5
8
4
8
8
8
1
0
5
8
8
8
5
8
6
8
0
0
0
0
Pre test
Post test
Tortuosity
1.000
1.000
Dilatation
0.552
1.000
Baseline Characteristics
Gender, n(%)
Male
19 (46%)
Female
22 (54%)
Maternal age (years)
Mean +SD
27.32 +6.6
Median (Range)
27.5 (16 – 42)
Birth weight (grams)
Mean +SD
1316.46 +314.0
Median (Range)
1300 (890 – 2200)
Gestational age (weeks)
Mean +SD
31 +1.9
Median (Range)
31 (26 – 34)
Postconceptional age (weeks)
Mean +SD
36 +4.1
Median (Range)
35 (30 – 51)
Rubeosis (right eye), n(%)
Present
2 (4.9)
Absent
39 (95.1)
Rubeosis (left eye), n(%)
Present
2 (4.9)
Absent
39 (95.1)
Risk factor classification
Risk factor
n(%)
Type of Oxygenation
Mechanical ventilation
7 (17.1)
CPAP
3 (7.3)
Nasal cannula/oxygen hood
7 (17.1)
Maternal/gestational risk factors
Infection
5 (12.2)
Placenta previa
0
Poor nutrition
1 (2.4)
Pre-eclampsia/ eclampsia
5 (12.2)
PPROM
13 (31.7)
Multiple gestation
3 (7.3)
Perinatal risk factors
Transfusion
12 (29.3)
Jaundice
3 (7.3)
Sepsis
3 (7.3)
Syndrome
0
Seizure
0
Respiratory distress
1 (2.44)
Risk factorclassification
Risk factor
Odds ratio (95% Conf. interval)
Dilatation
Tortuosity
Type of Oxygenation
MechanicalVentilation
-
6.22(1.10, 35.36)
CPAP
3.30(0.25, 43.47)
1.61(0.13, 19.91)
Nasal cannula/oxygen hood
3.0(0.43, 20.95)
2.89(0.52, 16.03)
Maternal/gestationalrisk factors
Infection
1.55(0.14, 16.85)
2.33(0.33, 16.47)
Placenta previa
-
-
Poor nutrition
-
-
Pre-eclampsia/ eclampsia
1.55(0.14, 16.85)
0.75(0.07, 7.61)
PPROM
2.5(0.43, 14.54)
1.63(0.37, 7.19)
Multiple gestation
-
-
Perinatal risk factors
Transfusion
1.25(0.20, 7.94)
3.43(0.77, 1.34)
Jaundice
3.3(0.25, 43.47)
-
Sepsis
3.3(0.25, 43.47)
7.5(0.60, 93.58)
Syndrome
-
-
Seizure
-
-
Respiratory distress
-
-
Other factors
Maternal age
0.90(0.76, 1.07)
0.93(0.82, 1.06)
Birth weight
0.99(0.99, 1.00)
1.00(0.998, 1.00)
Age of gestation
0.45(0.24, 0.84)
0.66(0.44, 1.00)
Risk factorClassification
Risk factor
Odds ratio(95% Conf. interval)
Type of Oxygenation
Mechanical Ventilation
2.42 (0.41, 11.20)
CPAP
3.07 (0.226, 36.88)
Nasal cannula/oxygen hood
2.15 (0.41, 11.20)
Maternal/gestationalrisk factors
Infection
2.36 (0.35, 15.93)
Placenta previa
-
Poor nutrition
-
Pre-eclampsia/ eclampsia
0.93 (0.14, 6.29)
PPROM
2.1 (0.55, 7.99)
Multiple gestation
-
Perinatal risk factors
Transfusion
7.87 (1.69, 36.72)
Jaundice
3.07 (0.26, 36.88)
Sepsis
-
Syndrome
-
Seizure
-
Respiratory distress
-
Other factors
Maternal age
0.95 (0.85, 1.06)
Birth weight
0.99(0.995, 1.000)
Age of gestation
0.48 (0.29, 0.78)
Retinopathy of Prematurity
Positive
Negative
p-value
Dilatation
Positive
6
0
0.004
Negative
12
23
Tortuosity
Positive
9
0
<0.05
Negative
9
23
Eye
Consultant
Resident
Total, n(%)
p-value
Positive
Negative
Right
Positive
6
0
6 (14.6)
0.317
Negative
1
34
35 (85.4)
Total, n(%)
7 (17.1)
34 (82.9)
41 (100.0)
Left
Positive
6
0
6 (14.6)
0.317
Negative
1
34
35 (85.4)
Total , n(%)
7 (17.1)
34 (82.9)
41 (100.0)
Eye
Consultant
Resident
Total
p-value
Positive
Negative
Right
Positive
6
3
9 (22.0)
0.083
Negative
0
32
32 (78.0)
Total
6 (14.6)
35 (85.4)
41 (100.0)
Left
Positive
7
2
9 (22.0)
0.564
Negative
1
31
32 (78.0)
Total
8 (19.5)
33 (80.5)
41 (100.0)
Discussion
Retinopathy of prematurity (ROP), previously known as retro-lental fibroplasia, was initially described by Terry in 1942. The pathogenesis of retinopathy of prematurity is biphasic. Retinopathy of prematurity has a multifactorial etiology. Prompt recognition of plus disease is crucial for timely treatment and management of retinopathy of prematurity. The detection of vascular and retinal changes in retinopathy of prematurity is hampered by technical difficulties. Therefore, the screening and management of retinopathy of prematurity is usually done by either a retina specialist or a pediatric ophthalmologist. In a developing country like the Philippines where ROP specialists are few in number, a retinopathy of prematurity screening protocol with general ophthalmologists in the provinces serving as the first line of examiners could hypothetically be more cost-effective, comprehensive, and efficient. This scenario will ensure that every infant needing retinal examination for ROP could be examined immediately for posterior pole vascular abnormalities by adequately trained general ophthalmologists. An appropriate referral system to an ROP specialist could then be instituted to allow proper and timely transfer to a secondary or tertiary health institution, for all high-risk ROP cases that would need immediate and appropriate medical and/or surgical intervention. Moreover, it should be emphasized that the findings of a normal retinal vessels at the time of examination does not rule out the potential of developing ROP in the future. Thus, repeated retinal examinations are suggested to document normal retinal vessels repeatedly or any vascular changes necessitating referral until the criteria for termination for ROP screening are met. One, however, must also consider that for this referral system to be successful, emphasis on the need for ROP training in the national ophthalmology residency program should also be established. Ophthalmology residents, who will soon be the general ophthalmologists in the provinces, should be comprehensively taught the concepts and skills needed to identify ophthalmologic findings suggestive of ROP, using the appropriate equipment. The limitations of this study are the small sample size and the sole utilization of retinal vascular dilatation and/or tortuosity as a manifestation of ROP. Since this study focused on a severe presentation of ROP, which is the presence of retinal vessel dilatation and tortuosity (plus disease) only, the results might not be applicable when evaluating less severe cases of retinopathy or prematurity. Based on the results of this study, we conclude that given sufficient and in-depth training, third year ophthalmologists, who will be general ophthalmologists in the future, can reliably identify eyes at risk for severe retinopathy of prematurity on the basis of retinal vascular dilatation and/or tortuosity. While this scenario may be far from the ideal setting for ROP screening, the role of general ophthalmologists in the provinces who are able to examined referred preterm babies provides an indispensible resource in health institutions where an on-site ROP specialist is not available.